Alector ALEC
NASDAQ ALEC
$2.46 -0.05 (-1.99%)
At close: Sep 4, 2026 · 4:00 PM EDT

Alector (ALEC) Other Accumulated Expenses (2018 - 2025)

Alector's (ALEC) quarterly Other Accumulated Expenses came in at $495000.0 in Q4 2025, up 2.7% year-over-year from $482000.0 in Q4 2024, and up 2.7% quarter-over-quarter from $482000.0 in Q4 2024.

Analysis

Alector (ALEC) Other Accumulated Expenses (2018 - 2025) Analysis & Trends

Alector (ALEC) has reported Other Accumulated Expenses for 8 consecutive years, with $495000.0 the latest figure, recorded in Q4 2025.

  • On a quarterly basis, Other Accumulated Expenses rose 2.7% year-over-year to $495000.0 in Q4 2025; TTM through Dec 2025 was $495000.0, a 2.7% increase from a year earlier, with the FY2025 full-year figure at $495000.0, up 2.7% from the prior year.
  • Other Accumulated Expenses was $495000.0 for Q4 2025 at Alector, up from $482000.0 in the prior quarter.
  • Over five years, Other Accumulated Expenses peaked at $709000.0 in Q4 2022 and troughed at $318000.0 in Q4 2021.
  • A 5-year average of $485400.0 and a median of $482000.0 in 2024 frame the typical range for Other Accumulated Expenses.
  • Across the five-year window, Other Accumulated Expenses soared 122.96% in 2022 and plunged 40.34% in 2023, its largest moves.
  • Over 5 years, Other Accumulated Expenses stood at $318000.0 in 2021, then jumped by 122.96% to $709000.0 in 2022, then tumbled by 40.34% to $423000.0 in 2023, then increased by 13.95% to $482000.0 in 2024, then gained by 2.7% to $495000.0 in 2025.
  • The last three Other Accumulated Expenses figures came in at $495000.0 (Q4 2025), $482000.0 (Q4 2024), and $423000.0 (Q4 2023), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn
10 Alector 274.68 Mn 101.88 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 495,000.00
Dec 31, 2024 482,000.00
Dec 31, 2023 423,000.00
Dec 31, 2022 709,000.00
Dec 31, 2021 318,000.00
Dec 31, 2020 353,000.00
Dec 31, 2019 615,000.00
Sep 30, 2019 122,000.00
Jun 30, 2019 156,000.00
Mar 31, 2019 165,000.00
Dec 31, 2018 971,000.00